Literature DB >> 11494026

Expression of the IL-6 family cytokines in human brain tumors.

A Lilja1, C Nordborg, A Brun, L G Salford, P Aman.   

Abstract

In our RT-PCR screen for cytokine expression in human brain tumors we discovered increased levels of oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF), all belonging to the interleukin-6 (IL-6) cytokine family, in most of the tumors. The expression of these cytokines in normal adult brain tissue was found to be very low or below detection limit. OSM expression was elevated in most of the tumors and immunohistochemistry analysis showed that the tumor cells contained OSM in their cytoplasm, suggesting they produce this factor. Overexpression of OSM has not previously been reported in primary human brain tumors. The IL-6 cytokine family acts through a common gp130 receptor subunit that activates the JAK/STAT signaling pathway and therefore they have been suggested to have overlapping effects. Tissue inhibitor of metalloproteinase-1 (TIMP-1), matrix metalloproteinase 1 (MMP-1) and MMP-3 and IL-6 have been reported to be regulated by OSM. IL-6 was low or absent in the tumors. TIMP-1, MMP-1 and MMP-3 was expressed in most tumors but with no strict correlation to OSM levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494026     DOI: 10.3892/ijo.19.3.495

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.

Authors:  Orin Bloch; Courtney A Crane; Rajwant Kaur; Michael Safaee; Martin J Rutkowski; Andrew T Parsa
Journal:  Clin Cancer Res       Date:  2013-04-23       Impact factor: 12.531

2.  Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.

Authors:  Desiree H Floyd; Benjamin Kefas; Oleksandr Seleverstov; Olga Mykhaylyk; Charli Dominguez; Laurey Comeau; Christian Plank; Benjamin Purow
Journal:  Neuro Oncol       Date:  2012-09-07       Impact factor: 12.300

3.  Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.

Authors:  Lena Jakob; Tony Andreas Müller; Michael Rassner; Helen Kleinfelder; Pia Veratti; Jan Mitschke; Cornelius Miething; Robert A J Oostendorp; Dietmar Pfeifer; Miguel Waterhouse; Justus Duyster
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

4.  Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.

Authors:  Lakshana Sreenivasan; Ling Vicky Li; Pascal Leclair; Chinten James Lim
Journal:  Cells       Date:  2022-01-23       Impact factor: 6.600

Review 5.  Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.

Authors:  Alessandra Caligiuri; Stefano Gitto; Giulia Lori; Fabio Marra; Maurizio Parola; Stefania Cannito; Alessandra Gentilini
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

6.  OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition.

Authors:  Hunter Covert; Liliana F Mellor; Cody L Wolf; Nicole Ankenbrandt; Jacqueline M Emathinger; Ken Tawara; Julie Thom Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2019-08-15       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.